{"id":"NCT02672852","sponsor":"AbbVie","briefTitle":"BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment","officialTitle":"BI 655066 / ABBV-066 (Risankizumab) Versus Placebo In a Multicenter Randomized Double-blind Study in Patients With Moderate to Severe Chronic Plaque Psoriasis Evaluating the Efficacy and Safety With Randomized Withdrawal and Re-treatment (IMMhance)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-02-29","primaryCompletion":"2017-08-02","completion":"2018-07-26","firstPosted":"2016-02-03","resultsPosted":"2019-05-28","lastUpdate":"2019-10-09"},"enrollment":507,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"Risankizumab","otherNames":["BI 655066","ABBV-066","SKYRIZI"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Risankizumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This was a multinational, multicenter, randomized, double-blind, placebo controlled study with randomized withdrawal and retreatment, evaluating the safety and efficacy of risankizumab 150 mg subcutaneous (SC) in participants with moderate to severe chronic plaque psoriasis.","primaryOutcome":{"measure":"Percentage of Participants Achieving 90% Improvement Psoriasis Area and Severity Index (PASI) Score (PASI90) From Baseline to Week 16","timeFrame":"Baseline, Week 16","effectByArm":[{"arm":"Placebo (Part A1)","deltaMin":2,"sd":null},{"arm":"Risankizumab (Part A1)","deltaMin":73.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":11},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["34921669","32267471","31667790","31054118"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":100},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Arthralgia","Headache","Back pain"]}}